Dashboard
Manage Tickers

PRAX Praxis Precision Medicines,...

Nasdaq praxismedicines.com


$ 159.12 $ -11.36 (-6.72 %)    

Wednesday, 05-Nov-2025 10:06:36 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.14 $ 3.69 (0.6 %)
DIA $ 472.20 $ 1.33 (0.28 %)
SPY $ 677.77 $ 2.73 (0.4 %)
TLT $ 89.23 $ -0.28 (-0.31 %)
GLD $ 365.66 $ -0.79 (-0.22 %)
$ 171.75
$ 168.54
$ 157.93 x 45
$ 160.26 x 100
$ 156.54 - $ 168.54
$ 26.70 - $ 206.71
668,731
na
3.61B
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-02-2025 03-31-2025 10-Q
4 02-28-2025 01-01-1970 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-05-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 02-07-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-17-2021 12-31-2020 10-K
21 11-23-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

praxis-precision-medicine-q3-eps-336-beats-343-estimate
Praxis Precision Medicine Q3 EPS $(3.36) B...
11/05/2025 13:04:23

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.36) per share which beat the analyst consensus estimat...

praxis-precision-aligns-with-fda-on-several-aspects-of-relutrigine-program-in-scn2a-and-scn8a-dees-including-use-of-ongoing-embold-study-to-serve-as-basis-of-substantial-evidence-of-effectiveness-for-nda-submission
Praxis Precision Aligns With FDA On Severa...
11/04/2025 13:07:40

Comprehensive meeting with FDA conducted in Q3 in conjunction with Breakthrough Therapy DesignationKey aspects of a potential N...

kimberly-clark-vertex-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Kimberly-Clark, Vertex And Other Big Stock...
11/03/2025 13:14:55

wedbush-maintains-underperform-on-praxis-precision-medicine-raises-price-target-to-73
Wedbush Maintains Underperform on Praxis P...
10/20/2025 13:14:32

Wedbush analyst Daniel Ives maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price targe...

revolution-medicines-disc-medicine-american-express-and-other-big-stocks-moving-higher-on-friday
Revolution Medicines, Disc Medicine, Ameri...
10/17/2025 16:02:18

truist-securities-reiterates-buy-on-praxis-precision-medicine-raises-price-target-to-360
Truist Securities Reiterates Buy on Praxis...
10/17/2025 13:58:42

Truist Securities analyst Joon Lee reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target...

guggenheim-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-350
Guggenheim Maintains Buy on Praxis Precisi...
10/17/2025 12:52:51

Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target fro...

chardan-capital-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-330
Chardan Capital Maintains Buy on Praxis Pr...
10/17/2025 11:54:24

Chardan Capital analyst Rudy Li maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target fro...

deutsche-bank-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-280
Deutsche Bank Maintains Buy on Praxis Prec...
10/17/2025 11:25:40

Deutsche Bank analyst David Hoang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target f...

why-csx-shares-are-trading-higher-by-over-4-here-are-20-stocks-moving-premarket
Why CSX Shares Are Trading Higher By Over ...
10/17/2025 09:55:54

reported-earlier-praxis-precision-medicines-prices-525m-public-offering-of-3025480-common-shares-at-157-and-318470-warrants-at-1569999-each
Reported Earlier, Praxis Precision Medicin...
10/17/2025 05:49:11

praxis-precision-medicines-announces-proposed-public-offering-no-terms-disclosed
Praxis Precision Medicines Announces Propo...
10/16/2025 20:05:09

Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into th...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 17:08:00

needham-maintains-buy-on-praxis-precision-medicine-raises-price-target-to-250
Needham Maintains Buy on Praxis Precision ...
10/16/2025 17:00:51

Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $80 ...

dow-dips-over-100-points-us-crude-oil-inventories-surge
Dow Dips Over 100 Points; US Crude Oil Inv...
10/16/2025 16:31:12

enerpac-tool-group-posts-upbeat-results-joins-praxis-precision-medicines-j-b-hunt-salesforce-and-other-big-stocks-moving-higher-on-thursday
Enerpac Tool Group Posts Upbeat Results, J...
10/16/2025 14:17:59

dow-surges-over-100-points-charles-schwab-posts-upbeat-earnings
Dow Surges Over 100 Points; Charles Schwab...
10/16/2025 14:00:35

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 12:08:17

praxis-precision-medicines-stock-doubles---heres-why
Praxis Precision Medicines Stock Doubles -...
10/16/2025 11:50:20

Praxis stock jumps after Phase 3 trials show ulixacaltamide significantly improves essential tremor symptoms and meets key effi...

praxis-precision-medicines-ulixacaltamide-hcl-study-1-for-essential-tremor-met-primary-endpoint-all-key-secondary-endpoints-in-study-1-were-also-statistically-significant
Praxis Precision Medicines' Ulixacaltamide...
10/16/2025 11:13:29

Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modif...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION